If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
556.00    -1.00 (-0.18%)
Bid:
555.00
Ask:
555.50
Spread: 0.50 (0.09%)
Market Cap: £2.46b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

8 Jul 2015 14:52

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) announces that it was informed yesterday that on 7 July 2015, a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (“Shares”) was made to Persons Discharging Managerial Responsibilities (“PDMR”) and to an Executive Director as follows:

1. PDMRs

Name Role Number of Shares subject to option* Number of Shares subject to award*
Rowan Adams PDMR 35,000 -
Joan Braca PDMR - 90,000
Robert Gibber PDMR 110,000 -
Rob Luijten PDMR 80,000 -
Gabrielle Parisse PDMR - 70,000
Pierre Schoumacher PDMR - 70,000

* Options are generally granted to UK residents and awards to non-UK residents.

The above options and awards will only vest to the extent that certain Company-based financial performance criteria are satisfied over a performance period which runs from 1 April 2015 to 31 March 2016. No consideration is payable for the grant or exercise of the options or awards. Options and awards will be subject to a 12-month deferral period and continued employment to 31 March 2017.

2. Nick Hampton

As explained on pages 71 and 72 of the Company’s Annual Report 2015, Nick Hampton, Chief Financial Officer, was granted an award in the form of a nil cost option over 121,781 ordinary shares of 25 pence each in the capital of the Company (the “Award”).

The Award was granted in connection with Mr Hampton’s recruitment as Chief Financial Officer and is intended to honour the agreement (announced on 24 June 2014) to compensate him for incentive awards that he forfeited at his previous employer.

The Award which is within the shareholder approved remuneration policy (for recruitment) has been granted following consultation with major shareholders. As a condition of the grant of the Award, Mr Hampton has surrendered the compensatory Award C that was granted to him on 18 November 2014 with a face value at the time of £1.44m.

The Award will be available for exercise by Mr Hampton after 31 March 2017.

Following the grant of the Award, the incentive arrangements relating to the recruitment of Mr Hampton are as follows:

Award name Date of grant Number of Shares subject to option Vesting Date
Award A 18/11/2014 96,681 01/09/15
Award B 18/11/2014 96,680 01/09/16
Award C – replacement 07/07/2015 121,781 After 31/03/17

All the above transactions took place in London.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FCA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

8 July 2015

Note:

Extract from the announcement issued on 24 June 2014:

To compensate Nick for incentive awards that he will forfeit at PepsiCo Europe, Tate & Lyle will make him a one-off Restricted Stock Award (RSA) of £1,200,000 worth of shares in Tate & Lyle (delivered in two equal tranches on the first and second anniversaries of his employment with Tate & Lyle subject to achievement of performance conditions) (Award A and B). In addition, he will receive a PSP award in 2014 of £1,440,000 worth of shares in Tate & Lyle (Award C). The foregoing RSA and PSP award will be subject to forfeiture/repayment if he ceases to be employed in the first 36 months of employment due to his resignation or dismissal for cause.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150708005829/en/

Copyright Business Wire 2015

Date   Source Headline
26th Jun 20245:38 pmRNSTransaction in Own Shares
25th Jun 20245:50 pmRNSTransaction in Own Shares
24th Jun 20245:35 pmRNSTransaction in Own Shares
24th Jun 20243:30 pmRNSHolding(s) in Company
21st Jun 20245:45 pmRNSTransaction in Own Shares
21st Jun 20242:45 pmRNSUpdate to the Notice of AGM 2024
20th Jun 20246:03 pmRNSTransaction in Own Shares
20th Jun 20247:05 amRNSLaunch of Share Buyback
20th Jun 20247:00 amRNSCombination of Tate & Lyle and CP Kelco
4th Jun 20245:22 pmRNSAnnual Financial Report and Notice of AGM
4th Jun 202411:00 amRNSDirector/PDMR Shareholding
3rd Jun 202412:00 pmRNSTotal Voting Rights
30th May 202412:15 pmRNSHolding(s) in Company
23rd May 20247:00 amRNSFinal Results
23rd May 20247:00 amRNSSale of remaining interest in Primient JV to KPS
20th May 20241:00 pmRNSDirectorate Change
17th May 20243:30 pmRNSHolding(s) in Company
14th May 20243:30 pmRNSHolding(s) in Company
13th May 202410:00 amRNSHolding(s) in Company
8th May 20243:15 pmRNSHolding(s) in Company
1st May 20242:30 pmRNSTotal Voting Rights
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSDirectorate Change
22nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
19th Apr 202410:15 amRNSHolding(s) in Company
17th Apr 20244:15 pmRNSHolding(s) in Company
17th Apr 202410:30 amRNSHolding(s) in Company
15th Apr 202410:30 amRNSHolding(s) in Company
10th Apr 20243:45 pmRNSHolding(s) in Company
8th Apr 202411:15 amRNSHolding(s) in Company
5th Apr 20243:45 pmRNSHolding(s) in Company
4th Apr 20244:15 pmRNSHolding(s) in Company
4th Apr 202412:30 pmRNSHolding(s) in Company
4th Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 202412:45 pmRNSTotal Voting Rights
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202411:45 amRNSHolding(s) in Company
25th Mar 202411:45 amRNSHolding(s) in Company
21st Mar 20244:10 pmRNSHolding(s) in Company
20th Mar 20243:00 pmRNSHolding(s) in Company
20th Mar 202412:00 pmRNSHolding(s) in Company
19th Mar 20242:00 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
12th Mar 20244:24 pmRNSHolding(s) in Company
12th Mar 20244:22 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSDirectorate Change
4th Mar 20242:00 pmRNSDirector/PDMR Shareholding
4th Mar 20241:45 pmRNSHolding(s) in Company
28th Feb 20242:30 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.